ROSTAB EZ

Rosuvastatin USP and Ezetimibe USP

Lipid Lowering Agents

 
 
 
 
 


Indication

Rostab EZ is indicated in adults

  • As an adjunct to diet in patients with primary non-familial Hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C).
  • Alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.


Dosage and Administration

Swallow Rostab EZ tablet whole at any time of day, with or without food. Do not crush, dissolve, or chew tablets.

The dosage range is 5 mg/10 mg to 40 mg/10 mg once daily. The recommended dose of Rostab EZ depends on a patient’s indication for usage, LDL-C, and individual risk for cardiovascular events.


Composition

Rostab EZ 5 Tablet: Each film coated tablet contains Rosuvastatin Calcium USP equivalent to Rosuvastatin 5 mg and Ezetimibe USP 10 mg.

Rostab EZ 10 Tablet: Each film coated tablet contains Rosuvastatin Calcium USP equivalent to Rosuvastatin 10 mg and Ezetimibe USP 10 mg.